Boston Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
CCA
1WCM
Boston Advisors's RGEN Position: Q3 2019 in Review
Boston Advisors increased its Repligen (RGEN) stake by 32% in Q3 2019, buying an estimated $445K and bringing the position to 20,879 shares worth $1.6M. The position accounts for 0.08% of the portfolio, ranked #294.
Boston Advisors first reported a position in RGEN in Q2 2015 and has held it in 18 quarters since. The position peaked at $6.21M in Q2 2018. 303 funds tracked by Wall St. Rank hold RGEN as of Q3 2019.
- Boston Advisors held 20,879 shares of Repligen worth $1.6M as of Q3 2019.
- Boston Advisors bought 5,087 Repligen shares in Q3 2019, an estimated $445K.
- Repligen made up 0.08% of Boston Advisors's portfolio in Q3 2019, its #294 holding.
- Boston Advisors first reported a position in Repligen in Q2 2015 and has held it in 18 quarters since.
- Boston Advisors's Repligen position peaked at $6.21M in Q2 2018.
- 303 funds tracked by Wall St. Rank held Repligen as of Q3 2019.
Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.